Vacquinol-1 (NSC13316) dihydrochloride is a MKK4-specific activator that activates the MAPK pathway; it specifically induces death of human glioblastoma cells (GC), slows tumor progression, and prolongs survival in a glioblastoma multiforme (GBM) mouse model; it also induces apoptosis in hepatocellular carcinoma (HCC) cells.